ARCHIVES

Conversation With The Cancer Letter: What $34,000 Per Patient Buys In Lung-MAP

This article is from The Cancer Letter archive.

Vol. 40 No. 25 | June 20, 2014

Download PDF Visit The Full Archive

Related Articles

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

Groups Offer Revisions to Kennedy-Hutchison Bill

May 15, 2009

FDA To Regulate Products From Human Cells, Tissue

March 21, 1997

Sullivan Accuses Tobacco Industry With “Lies, Blue smoke And Mirrors”

June 15, 1990

In Brief: DeVita, FDA Chief Help Kill California Bill Legalizing Laetrile Wit committee Testimony

August 26, 1977

Funding Opportunities.

March 15, 2002